Statera Biopharma, Inc. Quarterly Depreciation in USD from Q1 2011 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Statera Biopharma, Inc. quarterly/annual Depreciation history and growth rate from Q1 2011 to Q1 2022.
  • Statera Biopharma, Inc. Depreciation for the quarter ending March 31, 2022 was $6.52K, a 723% increase year-over-year.
  • Statera Biopharma, Inc. annual Depreciation for 2021 was $22.5K, a 2271% increase from 2020.
  • Statera Biopharma, Inc. annual Depreciation for 2020 was $947.000.
  • Statera Biopharma, Inc. annual Depreciation for 2018 was $18.2K, a 13.8% decline from 2017.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $6.52K +$5.73K +723% Jan 1, 2022 Mar 31, 2022 10-Q 2022-10-21
Q1 2021 $792 Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-21
Q1 2015 $38.6K -$19.2K -33.2% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-07
Q1 2014 $57.8K -$37.1K -39.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $94.9K -$32.5K -25.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $127K +$23.9K +23.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 $104K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.